N-(3-(5H-dibenzo[b,f]azepin-5-yl)propyl)acetamide | 1262142-19-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: N-(3-(5H-dibenzo[b,f]azepin-5-yl)propyl)acetamide
• 英文别名: N-(3-benzo[b][1]benzazepin-11-ylpropyl)acetamide
• CAS: 1262142-19-7
• 化学式: C₁₉H₂₀N₂O
• 分子量: 292.381
• InChiKey: OXFHCULNHNNNFL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(3-(5H-dibenzo[b,f]azepin-5-yl)propyl)acetamide 在 potassium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 反应 2.42h， 生成 (3-甲基氨基丙基)-5H-二苯并[b,f]氮杂卓
  参考文献：
  名称：

  A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential

  摘要：

  Overcoming the lack of effective treatments and the continuous clinical trial failures in neurodegenerative drug discovery might require a shift from the prevailing paradigm targeting pathogenesis to the one targeting simultaneously neuroprotection and neuroregeneration. In the studies reported herein, we sought to identify small molecules that might exert neuroprotective and neuroregenerative potential as tools against neurodegenerative diseases. In doing so, we started from the reported neuroprotective/neuroregenerative mechanisms of psychotropic drugs featuring a tricyclic alkylamine scaffold. Thus, we designed a focused-chemical library of 36 entries aimed at exploring the structural requirements for efficient neuroprotective/neuroregenerative cellular activity, without the manifestation of toxicity. To this aim, we developed a synthetic protocol, which overcame the limited applicability of previously reported procedures. Next, we evaluated the synthesized compounds through a phenotypic screening pipeline, based on primary neuronal systems. Phenothiazine 2Bc showed improved neuroregenerative and neuroprotective properties with respect to reference drug desipramine (2Aa). Importantly, we have also shown that 2Bc outperformed currently available drugs in cell models of Alzheimer's and Parkinson's diseases and attenuates microglial activation by reducing iNOS expression.

  DOI：

  10.1021/acschemneuro.8b00242
• 作为产物：
  描述：

  亚氨基芪 、 N-(3,3-dimethoxypropyl)acetamide 在 三乙基硅烷 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以71%的产率得到N-(3-(5H-dibenzo[b,f]azepin-5-yl)propyl)acetamide
  参考文献：
  名称：

  三乙基硅烷和TFA介导的苯胺与功能化缩醛直接一锅还原烷基化。不对称取代的乙二胺的简单路线

  摘要：

  已开发出一种新的，稳健而可靠的方法，使用TFA / Et 3 SiH作为试剂组合，可以通过一些官能化的缩醛选择性地将伯和仲芳族胺进行N-烷基选择性还原。一锅法可以在室温下以优异的收率合成多种不对称取代的乙二胺。与以前的合成方法相比，该新方法具有明显的优势，包括简洁，温和的反应条件，优异的收率和较高的官能团耐受性。

  DOI：

  10.1021/jo102109f

文献信息

• Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine
  作者：Marika Righi、Annalida Bedini、Giovanni Piersanti、Federica Romagnoli、Gilberto Spadoni

  DOI：10.1021/jo102109f

  日期：2011.1.21

  A new, robust, and reliable method has been developed for the selective reductive N-alkylation of primary and secondary aromatic amines with some functionalized acetals using TFA/Et3SiH as a reagent combination. A variety of unsymmetrically substituted ethylenediamines can be synthesized in a one-pot procedure in excellent yields at room temperature. This new procedure offers significant advantages

  已开发出一种新的，稳健而可靠的方法，使用TFA / Et 3 SiH作为试剂组合，可以通过一些官能化的缩醛选择性地将伯和仲芳族胺进行N-烷基选择性还原。一锅法可以在室温下以优异的收率合成多种不对称取代的乙二胺。与以前的合成方法相比，该新方法具有明显的优势，包括简洁，温和的反应条件，优异的收率和较高的官能团耐受性。
• A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential
  作者：Elisa Uliassi、Luis Emiliano Peña-Altamira、Aixa V. Morales、Francesca Massenzio、Sabrina Petralla、Michele Rossi、Marinella Roberti、Loreto Martinez Gonzalez、Ana Martinez、Barbara Monti、Maria Laura Bolognesi

  DOI：10.1021/acschemneuro.8b00242

  日期：2019.1.16

  Overcoming the lack of effective treatments and the continuous clinical trial failures in neurodegenerative drug discovery might require a shift from the prevailing paradigm targeting pathogenesis to the one targeting simultaneously neuroprotection and neuroregeneration. In the studies reported herein, we sought to identify small molecules that might exert neuroprotective and neuroregenerative potential as tools against neurodegenerative diseases. In doing so, we started from the reported neuroprotective/neuroregenerative mechanisms of psychotropic drugs featuring a tricyclic alkylamine scaffold. Thus, we designed a focused-chemical library of 36 entries aimed at exploring the structural requirements for efficient neuroprotective/neuroregenerative cellular activity, without the manifestation of toxicity. To this aim, we developed a synthetic protocol, which overcame the limited applicability of previously reported procedures. Next, we evaluated the synthesized compounds through a phenotypic screening pipeline, based on primary neuronal systems. Phenothiazine 2Bc showed improved neuroregenerative and neuroprotective properties with respect to reference drug desipramine (2Aa). Importantly, we have also shown that 2Bc outperformed currently available drugs in cell models of Alzheimer's and Parkinson's diseases and attenuates microglial activation by reducing iNOS expression.